Section of Haematology and Oncology
The Section of Haematology-Oncology of the Department of Medicine has seven full-time, fully-qualified specialists in these two fields, with expertise in the diagnosis and management of malignant diseases including acute and chronic leukemias, Hodgkin's disease and non-Hodgkin's lymphomas, other haematological malignancies, breast cancer, gynaecological malignancies, head and neck cancer, lung cancer, and other solid tumors. Weekly Tumour Board conferences discuss difficult management cases. Multidisciplinary conferences also include a breast planning conference and a conference related to bone malignancies. The Section works closely with the Department of Pathology and the Hospital's clinical laboratory. Apart from therapy and management, this Section is involved with expanding the use of current therapies such as high-dose chemotherapy with stem cell reinfusion, as well as modern international protocols of treatment.
Located in the University's Ibn Zuhr building, the Oncology Day Care unit is a specially designed facility for patients suffering from various blood and cancer conditions. The Day Care unit offers various diagnostic and therapeutic modalities including blood transfusions for patients with thalassemia, other types of blood component infusional therapy, and outpatient cancer chemotherapy for all types of malignant diseases. The Oncology Day Care unit has a total of 28 beds.
The Section is also actively involved in research and scholarly publication, designed to expand the existing medical knowledge base and improve patient care in the areas of blood diseases and cancer. Faculty members in the Section of Haematology-Oncology are among the most academically productive within the Department of Medicine, and areas of research focus include breast cancer management, febrile neutropenia, use of cytokine therapy in cancer, and leukemia/lymphoma.